Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NEURAMINIDASE INHIBITOR COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/022448
Kind Code:
A1
Abstract:
The present invention belongs to the pharmaceutical field. Specifically, the present invention relates to a neuraminidase inhibitor compound as represented by formula (I), or a stereoisomer, a tautomer, a nitrogen oxide, a solvate, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising the compound; and the use of the compound and the pharmaceutical composition thereof in the preparation of a drug for treating and/or preventing viral diseases or inhibiting neuraminidase activity. The compound provided can be released slowly, continuously and stably in vivo and a long-acting purpose is achieved.

Inventors:
CHEN HUIXUAN (CN)
KANG NING (CN)
LIU XIHONG (CN)
GUO CHEN (CN)
ZHANG JUFU (CN)
HE XIAOXI (CN)
WANG KUN (CN)
LI DEYAO (CN)
ZHANG LIJUN (CN)
Application Number:
PCT/CN2021/108383
Publication Date:
February 03, 2022
Filing Date:
July 26, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GUANGZHOU HENOVCOM BIOSCIENCE CO LTD (CN)
International Classes:
A61K31/215; C07C233/52; A61K31/22; A61K31/23; A61K31/337; A61K31/401; A61P31/16; C07C233/63; C07C235/14; C07C237/12; C07C279/16; C07D207/16; C07D305/08
Domestic Patent References:
WO2001080892A12001-11-01
WO2009129305A22009-10-22
WO2013070118A12013-05-16
Foreign References:
CN103108861A2013-05-15
CN1272105A2000-11-01
US5763483A1998-06-09
CN104284884A2015-01-14
CN104640540A2015-05-20
Other References:
DATABASE REGISTRY 9 August 2016 (2016-08-09), ANONYMOUS : "L-Valine, 1-[[[(3R,4R,5S)-4-(acetylamino)-5-[(aminoiminomethyl)amino]-3-(1- ethylpropoxy)-1-cyclohexen-1-yl]carbonyl]oxy]-2-methylpropyl ester (CA INDEX NAME)", XP055890986, retrieved from STN Database accession no. 1970223-82-5
Attorney, Agent or Firm:
GUANGZHOU SINO PATENT & TRADEMARK AGENT CO., LTD. (CN)
Download PDF: